BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 6398817)

  • 1. Experience with the use of mizoribine in human renal transplantation.
    Dohi K; Yahata H; Fukuda Y; Takenaka M; Tabe Y; Ono E; Fukuda M; Omotehara T; Eto T; Ezaki H
    Hiroshima J Med Sci; 1984 Dec; 33(4):809-12. PubMed ID: 6398817
    [No Abstract]   [Full Text] [Related]  

  • 2. Advantages of mizoribine over azathioprine in combination therapy with cyclosporine for renal transplantation.
    Mita K; Akiyama N; Nagao T; Sugimoto H; Inoue S; Osakabe T; Nakayama Y; Yokota K; Sato K; Uchida H
    Transplant Proc; 1990 Aug; 22(4):1679-81. PubMed ID: 2202125
    [No Abstract]   [Full Text] [Related]  

  • 3. A new triple-drug induction therapy with low dose cyclosporine, mizoribine and prednisolone in renal transplantation.
    Kokado Y; Ishibashi M; Jiang H; Takahara S; Sonoda T
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1575-8. PubMed ID: 2652512
    [No Abstract]   [Full Text] [Related]  

  • 4. Mizoribine as an alternative to azathioprine in pediatric renal transplantation.
    Faraj G; Cochat P; Serre-Beauvais F; Vialtel P; Chevallier C; Cuzin B; Bouvier R; Lachaux A
    Transplantation; 1996 Dec; 62(11):1701-2. PubMed ID: 8970640
    [No Abstract]   [Full Text] [Related]  

  • 5. Application of mizoribine after keratoplasty and in the treatment of uveitis.
    Nakajima A; Kanai A; Minami S; Kogure M
    Am J Ophthalmol; 1985 Jul; 100(1):161-3. PubMed ID: 3893138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Suppression of corneal graft rejection in rabbits by mizoribine].
    Minami S; Kanai A; Murakami A; Awata T
    Nippon Ganka Gakkai Zasshi; 1986 Dec; 90(12):1448-54. PubMed ID: 3548274
    [No Abstract]   [Full Text] [Related]  

  • 7. Mizoribine as an alternative to azathioprine in triple-therapy immunosuppressant regimens in cadaveric renal transplantation.
    Lee HA; Slapak M; Venkatraman G; Mason J; Digard N; Wise M
    Transplant Proc; 1993 Aug; 25(4):2699-700. PubMed ID: 8356720
    [No Abstract]   [Full Text] [Related]  

  • 8. Experience with administration of 15-deoxyspergualin in rejection in kidney transplant recipients.
    Jiang H; Takahara S; Takano Y; Kokado Y; Kameoka H; Moutabarrik A; Ishibashi M; Okuyama A; Sonoda T
    Transplant Proc; 1992 Oct; 24(5):1726-9. PubMed ID: 1412813
    [No Abstract]   [Full Text] [Related]  

  • 9. Synergistically enhanced immunosuppressive effect by combined use of cyclosporine and mizoribine.
    Amemiya H; Suzuki S; Watanabe H; Hayashi R; Niiya S
    Transplant Proc; 1989 Feb; 21(1 Pt 1):956-8. PubMed ID: 2650298
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical use of mizoribine (Bredinin) and pharmacologic monitoring assessment in renal transplantation.
    Zaoui P; Serre-Debeauvais F; Bayle F; Bessard G; Pintar P; Deteix P; Janbon B; Vialtel P
    Transplant Proc; 1995 Feb; 27(1):1064-5. PubMed ID: 7878806
    [No Abstract]   [Full Text] [Related]  

  • 11. Synergistic effect of cyclosporine and mizoribine on graft survival in canine organ transplantation.
    Hayashi R; Suzuki S; Shimatani K; Watanabe H; Kenmochi T; Fukuoka T; Niiya S; Amemiya H
    Transplant Proc; 1990 Aug; 22(4):1676-8. PubMed ID: 2389432
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunosuppression with low-dose cyclosporine, mizoribine, and steroids in living-related kidney transplantation.
    Takeuchi N; Ohshima S; Matsuura O; Ono Y; Katoh N; Yamada S; Fujita T; Kinukawa T; Hirabayashi S; Sahashi M
    Transplant Proc; 1994 Aug; 26(4):1907-9. PubMed ID: 8066621
    [No Abstract]   [Full Text] [Related]  

  • 13. Studies on immunosuppression with low-dose cyclosporine combined with mizoribine in experimental and clinical cadaveric renal allotransplantation.
    Osakabe T; Uchida H; Masaki Y; Yokota K; Sato K; Nakayama Y; Ohkubo M; Kumano K; Endo T; Watanabe K
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1598-600. PubMed ID: 2652520
    [No Abstract]   [Full Text] [Related]  

  • 14. Mizoribine as an alternative to azathioprine in triple therapy immunosuppressant regimens in cadaveric renal transplantation: two successive studies.
    Lee HA; Slapak M; Raman GV; Mason JC; Digard N; Wise M
    Transplant Proc; 1995 Feb; 27(1):1050-1. PubMed ID: 7878799
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunosuppressive effect of bredinin in the management of patients with renal transplantation.
    Kusaba R; Otubo O; Sugimoto H; Takahashi I; Yamada Y; Yamauchi J; Akiyama N; Inou T
    Proc Eur Dial Transplant Assoc; 1981; 18():420-5. PubMed ID: 7036163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunopharmacologic effects of immunosuppressive agents explored by a new effector monocyte generation assay.
    Ishibashi M; Jiang S; Kokado Y; Takahara S; Sonoda T
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1854-8. PubMed ID: 2469228
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical pharmacokinetic study of mizoribine in renal transplantation patients.
    Sonda K; Takahashi K; Tanabe K; Funchinoue S; Hayasaka Y; Kawaguchi H; Teraoka S; Toma H; Ota K
    Transplant Proc; 1996 Dec; 28(6):3643-8. PubMed ID: 8962403
    [No Abstract]   [Full Text] [Related]  

  • 18. Use of 15-deoxyspergualin in treatment of acute rejection in kidney transplant patients.
    Takahara S; Moutabarrik A; Kokado Y; Kameoka H; Takano Y; Zaid D; Ishibashi M; Sonoda T; Okuyama A
    Transplant Proc; 1993 Jun; 25(3):2254-8. PubMed ID: 8516891
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of a novel immunosuppressive agent, deoxyspergualin, on rejection in kidney transplant recipients.
    Takahashi K; Ota K; Tanabe K; Oba S; Teraoka S; Toma H; Agishi T; Kawaguchi H; Ito K
    Transplant Proc; 1990 Aug; 22(4):1606-12. PubMed ID: 2389420
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical application of bredinin].
    Aso Y; Tajima A
    Nihon Rinsho; 1985 Jan; 43(1):136-40. PubMed ID: 3886953
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.